Authors: Nahum, A Hirsch, K Danilenko, M Watts, CKW Prall, OWJ Levy, J Sharoni, Y

Citation: A. Nahum et al., Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention ofp27(Kip1) in the cyclin E-cdk2 complexes, ONCOGENE, 20(26), 2001, pp. 3428-3436

Authors: Prall, OWJ Carroll, JS Sutherland, RL

Citation: Owj. Prall et al., A low abundance pool of nascent p21(WAF1/Cip1) is targeted by estrogen to activate cyclin E-Cdk2, J BIOL CHEM, 276(48), 2001, pp. 45433-45442

Authors: Lai, A Sarcevic, B Prall, OWJ Sutherland, RL

Citation: A. Lai et al., Insulin/Insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1), J BIOL CHEM, 276(28), 2001, pp. 25823-25833

Authors: Carroll, JS Prall, OWJ Musgrove, EA Sutherland, RL

Citation: Js. Carroll et al., A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breastcancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence, J BIOL CHEM, 275(49), 2000, pp. 38221-38229